Topical Squalamine in the Treatment of Retinal Neovascularization From Proliferative Diabetic Retinopathy

Trial Profile

Topical Squalamine in the Treatment of Retinal Neovascularization From Proliferative Diabetic Retinopathy

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Feb 2015

At a glance

  • Drugs Squalamine (Primary)
  • Indications Diabetic retinopathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Feb 2015 According to an Ohr Pharmaceutical media release, final data for this trial is expected in the first half of 2015.
    • 09 Feb 2015 Status changed from recruiting to completed,as reported by ClinicalTrials.gov.
    • 10 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top